Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

In vitro gliadin challenge: diagnostic accuracy and utility for the difficult diagnosis of celiac disease.

Tortora R, Russo I, De Palma GD, Luciani A, Rispo A, Zingone F, Iovino P, Capone P, Ciacci C.

Am J Gastroenterol. 2012 Jan;107(1):111-7. doi: 10.1038/ajg.2011.311.

PMID:
21946279
2.

Difficult diagnosis of celiac disease: diagnostic accuracy and utility of chromo-zoom endoscopy.

Iovino P, Pascariello A, Russo I, Galloro G, Pellegrini L, Ciacci C.

Gastrointest Endosc. 2013 Feb;77(2):233-40. doi: 10.1016/j.gie.2012.09.036.

PMID:
23200727
3.

Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease.

Lähteenoja H, Mäki M, Viander M, Räihä I, Vilja P, Rantala I, Toivanen A, Syrjänen S.

Am J Gastroenterol. 2000 Oct;95(10):2880-7.

PMID:
11051363
4.

Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis.

Carroccio A, Iacono G, D'Amico D, Cavataio F, Teresi S, Caruso C, Di PL, Colombo A, D'Arpa F, Florena A, Notarbartolo A, Montalto G.

Scand J Gastroenterol. 2002 Jan;37(1):32-8.

PMID:
11843032
5.

Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.

Bucci C, Zingone F, Russo I, Morra I, Tortora R, Pogna N, Scalia G, Iovino P, Ciacci C.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1294-1299.e1. doi: 10.1016/j.cgh.2013.04.022.

PMID:
23639603
6.

Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.

Ciacci C, Maiuri L, Russo I, Tortora R, Bucci C, Cappello C, Santonicola A, Luciani A, Passananti V, Iovino P.

Clin Exp Pharmacol Physiol. 2009 Dec;36(12):1170-6. doi: 10.1111/j.1440-1681.2009.05211.x.

PMID:
19473192
7.

Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children.

Bonamico M, Sabbatella L, Di Tola M, Vetrano S, Ferri M, Nenna R, Mariani P, Picarelli A.

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):165-9; discussion 122-4.

PMID:
15699690
8.

Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I.

J Clin Lab Anal. 2009;23(3):165-71. doi: 10.1002/jcla.20313.

PMID:
19455636
9.

The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea.

Barbato M, Maiella G, Di Camillo C, Guida S, Valitutti F, Lastrucci G, Mainiero F, Cucchiara S.

Dig Liver Dis. 2011 Jun;43(6):465-9. doi: 10.1016/j.dld.2010.12.006.

PMID:
21257356
10.

Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test.

Brottveit M, Ráki M, Bergseng E, Fallang LE, Simonsen B, Løvik A, Larsen S, Løberg EM, Jahnsen FL, Sollid LM, Lundin KE.

Am J Gastroenterol. 2011 Jul;106(7):1318-24. doi: 10.1038/ajg.2011.23. Erratum in: Am J Gastroenterol. 2012 Apr;107(4):638.

PMID:
21364548
11.

Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.

Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):55-60. doi: 10.1097/MPG.0b013e3182145511.

PMID:
21694536
12.

Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions.

Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, Weir DG.

Dig Dis Sci. 1991 Jun;36(6):743-51.

PMID:
2032515
13.

IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.

Zanzi D, Stefanile R, Santagata S, Iaffaldano L, Iaquinto G, Giardullo N, Lania G, Vigliano I, Vera AR, Ferrara K, Auricchio S, Troncone R, Mazzarella G.

Am J Gastroenterol. 2011 Jul;106(7):1308-17. doi: 10.1038/ajg.2011.80.

PMID:
21468011
14.

Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.

Pizzuti D, Buda A, D'Odorico A, D'Incà R, Chiarelli S, Curioni A, Martines D.

Scand J Gastroenterol. 2006 Nov;41(11):1305-11.

PMID:
17060124
15.

Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.

Sugai E, Vázquez H, Nachman F, Moreno ML, Mazure R, Smecuol E, Niveloni S, Cabanne A, Kogan Z, Gómez JC, Mauriño E, Bai JC.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1112-7.

PMID:
16860613
16.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

17.

The diagnostic value of the gliadin antibody test in celiac disease in children: a prospective study.

Bodé S, Weile B, Krasilnikoff PA, Gudmand-Høyer E.

J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):260-4.

PMID:
8271124
18.

Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in blood.

Di Sabatino A, Rovedatti L, Rosado MM, Carsetti R, Corazza GR, MacDonald TT.

Hum Pathol. 2009 May;40(5):699-704. doi: 10.1016/j.humpath.2008.10.014.

PMID:
19157500
19.

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, Wild G, Sanders DS.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):314-20. doi: 10.1016/j.cgh.2007.12.008.

PMID:
18328437
20.

Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.

Vitoria JC, Arrieta A, Arranz C, Ayesta A, Sojo A, Maruri N, García-Masdevall MD.

J Pediatr Gastroenterol Nutr. 1999 Nov;29(5):571-4.

PMID:
10554125
Items per page

Supplemental Content

Support Center